SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-13-000016
Filing Date
2013-08-14
Accepted
2013-08-14 07:03:55
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20130630x10q.htm 10-Q 1444153
8 EX-31.1 supn-20130630ex3110132d0.htm EX-31.1 13053
9 EX-31.2 supn-20130630ex312f567f0.htm EX-31.2 13749
10 EX-32.1 supn-20130630ex321beaa17.htm EX-32.1 9672
11 EX-32.2 supn-20130630ex322d94fa9.htm EX-32.2 9079
  Complete submission text file 0001356576-13-000016.txt   9918114

Data Files

Seq Description Document Type Size
2 EX-101.CAL supn-20130630_cal.xml EX-101.CAL 50072
3 EX-101.DEF supn-20130630_def.xml EX-101.DEF 75474
4 EX-101.INS supn-20130630.xml EX-101.INS 1247354
5 EX-101.LAB supn-20130630_lab.xml EX-101.LAB 356390
6 EX-101.PRE supn-20130630_pre.xml EX-101.PRE 220806
7 EX-101.SCH supn-20130630.xsd EX-101.SCH 35689
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 131034918
SIC: 2834 Pharmaceutical Preparations